-
12261“…The result showed overall prevalence rates for hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) were 21.2 % and 2.9 %, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12262Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africapor Kuniholm, Mark H., Lesi, Olufunmilayo A., Mendy, Maimuna, Akano, Aliu O., Sam, Omar, Hall, Andrew J., Whittle, Hilton, Bah, Ebrima, Goedert, James J., Hainaut, Pierre, Kirk, Gregory D.“…Blood samples were tested for hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), hepatitis C virus (HCV) antibody, HCV RNA, and the aflatoxin-associated 249(ser) TP53 mutation. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12263por Adamidou, Alexandra, Kotsaftis, Panagiotis, Vlachou, Maria, Haritanti, Afroditi, Xanthakis, Ioannis, Zantidis, Anestis, Ntaios, George“…Other biochemical tests including tumor markers, thyroid hormones, antithyroid antibodies, hepatitis B and hepatitis C antibodies were negative. Imaging methods revealed enlargement of the left thyroid lobe extending to the anterior mediastinum and compressing the trachea, metastatic bilateral pulmonary lesions and a large, nodular, contrast-enhanced mass-occupying lesion in the right hepatic lobe. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12264“…Serologic tests for hepatitis B, hepatitis C, anti-nuclear antibodies, anti-glomerular basement membrane antibodies and anti-neutrophil cytoplasmic antibodies were negative. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12265“…BACKGROUND: Hepatitis C virus (HCV) encodes two transmembrane glycoproteins E1 and E2 which form a heterodimer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12266por Nakamoto, Nobuhiro, Cho, Hyosun, Shaked, Abraham, Olthoff, Kim, Valiga, Mary E., Kaminski, Mary, Gostick, Emma, Price, David A., Freeman, Gordon J., Wherry, E. John, Chang, Kyong-Mi“…A similar effect was observed in circulating HCV-specific CD8 T cells with increased PD-1/CTLA-4 co-expression during acute hepatitis C. The functional response to combined blockade was directly associated with CTLA-4 expression, lost with CD28-depletion and CD4-independent (including CD4(+)FoxP3(+) Tregs). …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12267HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Micepor Joyce, Michael A., Walters, Kathie-Anne, Lamb, Sue-Ellen, Yeh, Mathew M., Zhu, Lin-Fu, Kneteman, Norman, Doyle, Jason S., Katze, Michael G., Tyrrell, D. Lorne“…Hepatitis C virus (HCV) is a blood-borne pathogen and a major cause of liver disease worldwide. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12268por Hoare, Matthew, Gelson, William T H, Rushbrook, Simon M, Curran, Martin D, Woodall, Tracy, Coleman, Nicholas, Davies, Susan E, Alexander, Graeme J M“…It is unclear whether hepatitis C virus (HCV) has been eradicated or persists at a low level in HCV antibody–positive HCV RNA–negative individuals. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12269“…Immune thrombocytopenia can be secondary to medications or to a concurrent disease, such as an autoimmune condition (eg, systemic lupus erythematosus [SLE], antiphospholipid antibody syndrome [APS], immune thyroid disease, or Evans syndrome), a lymphoproliferative disease (eg, chronic lymphocytic leukemia or large granular T-lymphocyte lymphocytic leukemia), or chronic infection, eg, with Helicobacter pylori, human immunodeficiency virus (HIV), or hepatitis C virus (HCV). Response to infection may generate antibodies that cross-react with platelet antigens (HIV, H pylori) or immune complexes that bind to platelet Fcγ receptors (HCV), and platelet production may be impaired by infection of megakaryocyte (MK) bone marrow–dependent progenitor cells (HCV and HIV), decreased production of thrombopoietin (TPO), and splenic sequestration of platelets secondary to portal hypertension (HCV). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12270por Kerr, Thomas, Marshall, Brandon DL, Miller, Cari, Shannon, Kate, Zhang, Ruth, Montaner, Julio SG, Wood, Evan“…Factors associated with injection drug use in multivariate analyses included age ≥ 22 years (adjusted odds ratio [AOR] = 1.18, 95% CI: 1.10–1.28); sex work involvement (AOR = 2.17, 95% CI: 1.35–3.50); non-fatal overdose (AOR = 2.10, 95% CI: 1.38–3.20); and hepatitis C (HCV) infection (AOR = 22.61, 95% CI: 7.78–65.70). …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12271por Rögnvaldsson, Thorsteinn, Etchells, Terence A, You, Liwen, Garwicz, Daniel, Jarman, Ian, Lisboa, Paulo JG“…It is demonstrated on substrate data sets for human immunodeficiency virus type 1 (HIV-1) protease and hepatitis C (HCV) NS3/4A protease, showing excellent prediction performance for both HIV-1 cleavage and HCV NS3/4A cleavage, agreeing with observed HCV genotype differences. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12272por Ryder, Niamh, Cullen, Walter, Barry, Joseph, Bury, Gerard, Keenan, Eamon, Smyth, Bobby P“…The median age was 32 years, 55% were hepatitis C positive, 79% had used illicit drugs in the previous month and 68% were male. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12273“…The causes of cirrhosis included: alcohol - 44; Hepatitis C - 30; Hepatitis B - 6; non-alcoholic steatohepatitis - 7; cryptogenic - 18; other single causes - 6; and multifactorial (alcohol and hepatitis viruses) - 22. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12274“…Among prisoners who underwent testing, 7.3% had a positive chlamydia test result and 24.8% had a positive hepatitis C test result. CONCLUSION: The documented coverage of STI and BBV testing among prisoners in Western Australia is not comprehensive, and varies significantly by age, gender and Aboriginality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12275por Parameswaran, Poornima, Sklan, Ella, Wilkins, Courtney, Burgon, Trever, Samuel, Melanie A., Lu, Rui, Ansel, K. Mark, Heissmeyer, Vigo, Einav, Shirit, Jackson, William, Doukas, Tammy, Paranjape, Suman, Polacek, Charlotta, dos Santos, Flavia Barreto, Jalili, Roxana, Babrzadeh, Farbod, Gharizadeh, Baback, Grimm, Dirk, Kay, Mark, Koike, Satoshi, Sarnow, Peter, Ronaghi, Mostafa, Ding, Shou-Wei, Harris, Eva, Chow, Marie, Diamond, Michael S., Kirkegaard, Karla, Glenn, Jeffrey S., Fire, Andrew Z.“…Using populations of cells carrying a Hepatitis C replicon, we observed strand-selective loading of siRNAs onto Argonaute complexes. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12276“…BACKGROUND: CD56(+) T cells are abundant in liver and play an important role in host innate immunity against viral infections, including hepatitis C virus (HCV) infection, a common infection among heroin abusers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12277por Murayama, Asako, Weng, Leiyun, Date, Tomoko, Akazawa, Daisuke, Tian, Xiao, Suzuki, Tetsuro, Kato, Takanobu, Tanaka, Yasuhito, Mizokami, Masashi, Wakita, Takaji, Toyoda, Tetsuya“…We have previously reported that the NS3 helicase (N3H) and NS5B-to-3′X (N5BX) regions are important for the efficient replication of hepatitis C virus (HCV) strain JFH-1 and viral production in HuH-7 cells. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12278por Marrero, Domingo, Hernandez, Domingo, Tamajón, Lourdes Pérez, Rivero, Manuel, Lampreabe, Ildefonso, Checa, Maria Dolores, Gonzalez-Posada, Jose Manuel“…On multivariate analysis, independent risk factors associated with the development of NODAT were: recipient age [odds ratio (OR): 1.060, P = 0.0001], tacrolimus (OR: 1.611, P = 0.005), triglycerides (OR: 1.511, P = 0.018), positive hepatitis C virus (HCV) status (OR: 1.969, P = 0.001) and pre-transplant body mass index (BMI) (OR: 1.135, P = 0.0001), but not the weight gain. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12279por DallaPiazza, Michelle, Amorosa, Valerianna K, Localio, Russell, Kostman, Jay R, Lo Re, Vincent“…METHODS: We conducted a cross-sectional study among HIV-infected patients negative for hepatitis B surface antigen and hepatitis C antibody in the Penn Center for AIDS Research Adult/Adolescent Database. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
12280“…Although RBV is approved for the treatment of hepatitis C virus, respiratory syncytial virus, and Lassa fever virus infections, its mechanism of action and therapeutic efficacy remains highly controversial. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto